| Literature DB >> 27075316 |
G Beyer1, I Küster2, C Budde3, E Wilhelm3, A Hoene4, K Evert5, S Stracke3, S Friesecke6, J Mayerle3, A Steveling3.
Abstract
A 23-year-old woman with preexisting Graves' disease who received thiamazole treatment presented with fever, dysphagia, hyperthyroidism and leukopenia. With suspicion of thyreotoxicosis accompanied by drug-induced agranulocytosis she was successfully managed by plasmapheresis, G‑CSF administration and inhibition of periphereal conversion of thyroid hormones. In due course she underwent thyroidectomy. Thiamazole is frequently associated with drug-induced agranulocytosis. Long-term therapy with thiamazole requires critical evaluation and alternatives should be considered early. Plasmapheresis is an adequate treatment option to achieve normal thyroid hormonal status.Entities:
Keywords: Agranulocytosis; Graves’ disease; Plasmapheresis; Thiamazole, adverse effects; Thyrotoxicosis
Mesh:
Substances:
Year: 2016 PMID: 27075316 DOI: 10.1007/s00108-016-0044-8
Source DB: PubMed Journal: Internist (Berl) ISSN: 0020-9554 Impact factor: 0.743